about
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodys...
Read More
7.02
-0.10
(-1.40%)
30,670.3
XNAS Volume
XNAS 12 Mar, 2026 4:00 PM (EDT)
Board Meeting
The next board meeting for Kyntra Bio Inc is on 17 Mar 2026 for the purpose of FibroGen Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Mid Valuation
Technically Neutral
Kyntra Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..